# From Volume to Value: Role of AI in Redefining Indian Pharma's Leadership for Viksit Bharat 2047

**India AI Impact Summit 2026 â€” Day 3 (2026-02-18)**

---

## ğŸ“Œ Session Details

| | |
|---|---|
| â° **Time** | 11:30 â€“ 12:30 |
| ğŸ“ **Venue** | Bharat Mandapam | West Wing Room 4 B |
| ğŸ“… **Date** | 2026-02-18 |
| ğŸ¥ **Video** | [â–¶ï¸ Watch on YouTube](https://youtube.com/live/z3Fp8b_1h7Y?feature=share) |

## ğŸ¤ Speakers

- Dr Amit Sheth, Indian AI Research Organisation
- Dr Sharvil Patel, Zydus Lifesciences
- Mr Sudarshan Jain, Indian Pharmaceutical Alliance (IPA)
- Mr Winselow Tucker, Eli Lilly (India)
- Priyanka Aggarwal, BCG

## ğŸ¤ Knowledge Partners

- Indian Pharmaceutical Alliance (IPA)

## ğŸ“ Summary

AI can accelerate Indian pharmaceutical innovation â€“ driving economic growth and social good. The discussion will focus on how organizations can deploy AI across R&D and operations and scale responsibly to improve access to affordable innovative medicines. It will also address the ecosystem and policy enablers required for India to move up the value chain and advance the Viksit Bharat 2047 vision.

## ğŸ”‘ Key Takeaways

1. AI can accelerate Indian pharmaceutical innovation â€“ driving economic growth and social good.
2. The discussion will focus on how organizations can deploy AI across R&D and operations and scale responsibly to improve access to affordable innovative medicines.
3. It will also address the ecosystem and policy enablers required for India to move up the value chain and advance the Viksit Bharat 2047 vision.

## ğŸ“º Video

[![Watch on YouTube](https://img.youtube.com/vi/z3Fp8b_1h7Y/maxresdefault.jpg)](https://youtube.com/live/z3Fp8b_1h7Y?feature=share)

---

_[â† Back to Day 3 Sessions](../README.md)_
